Cargando…

Pregnancy testing in patients undergoing radiation therapy

Radiation therapy (RT) can be lethal to a developing fetus; therefore, determining pregnancy status before RT is essential. We here sought to determine how many women treated with RT at our institution for over one year were at risk for pregnancy when starting RT. We retrospectively reviewed the med...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharod, Shivam M, Greenwalt, Julie, Dessaigne, Camille, Yeung, Anamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533601/
https://www.ncbi.nlm.nih.gov/pubmed/28798811
http://dx.doi.org/10.3332/ecancer.2017.753
_version_ 1783253645876264960
author Kharod, Shivam M
Greenwalt, Julie
Dessaigne, Camille
Yeung, Anamaria
author_facet Kharod, Shivam M
Greenwalt, Julie
Dessaigne, Camille
Yeung, Anamaria
author_sort Kharod, Shivam M
collection PubMed
description Radiation therapy (RT) can be lethal to a developing fetus; therefore, determining pregnancy status before RT is essential. We here sought to determine how many women treated with RT at our institution for over one year were at risk for pregnancy when starting RT. We retrospectively reviewed the medical records of all female patients 12–55 years old treated with radiation, i.e. 1 October 2012 to 31 September 2013. Patients were categorised as ‘at risk’ if they had a uterus and ‘no risk’ if they had a hysterectomy. Documented birth control, pregnancy test status, and timing of the pregnancy test in relation to the radiation start date were recorded. We included 131 female patients with a median age of 48 years (range 14–55 years). Breast cancer was the most prevalent disease site (18%) followed by head/neck and central nervous system (both 11%). Of the 131 patients, 35 were deemed ‘no risk’ and 95 (72%) were ‘at risk’. Pregnancy testing of the ‘at risk’ population was done in 47%, but only 17% of the pregnancy testing was performed accurately, which we defined as a test performed within 14 days before starting RT. Over one year, 66% (63/95) of ‘at risk’ women were not tested appropriately before starting RT. Most (66%) women of child-bearing age with an intact uterus receiving RT at our institution were not appropriately tested for pregnancy before the initiation of RT. These data laid the foundation for our formal pregnancy testing policies for women undergoing RT.
format Online
Article
Text
id pubmed-5533601
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-55336012017-08-10 Pregnancy testing in patients undergoing radiation therapy Kharod, Shivam M Greenwalt, Julie Dessaigne, Camille Yeung, Anamaria Ecancermedicalscience Research Radiation therapy (RT) can be lethal to a developing fetus; therefore, determining pregnancy status before RT is essential. We here sought to determine how many women treated with RT at our institution for over one year were at risk for pregnancy when starting RT. We retrospectively reviewed the medical records of all female patients 12–55 years old treated with radiation, i.e. 1 October 2012 to 31 September 2013. Patients were categorised as ‘at risk’ if they had a uterus and ‘no risk’ if they had a hysterectomy. Documented birth control, pregnancy test status, and timing of the pregnancy test in relation to the radiation start date were recorded. We included 131 female patients with a median age of 48 years (range 14–55 years). Breast cancer was the most prevalent disease site (18%) followed by head/neck and central nervous system (both 11%). Of the 131 patients, 35 were deemed ‘no risk’ and 95 (72%) were ‘at risk’. Pregnancy testing of the ‘at risk’ population was done in 47%, but only 17% of the pregnancy testing was performed accurately, which we defined as a test performed within 14 days before starting RT. Over one year, 66% (63/95) of ‘at risk’ women were not tested appropriately before starting RT. Most (66%) women of child-bearing age with an intact uterus receiving RT at our institution were not appropriately tested for pregnancy before the initiation of RT. These data laid the foundation for our formal pregnancy testing policies for women undergoing RT. Cancer Intelligence 2017-07-19 /pmc/articles/PMC5533601/ /pubmed/28798811 http://dx.doi.org/10.3332/ecancer.2017.753 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kharod, Shivam M
Greenwalt, Julie
Dessaigne, Camille
Yeung, Anamaria
Pregnancy testing in patients undergoing radiation therapy
title Pregnancy testing in patients undergoing radiation therapy
title_full Pregnancy testing in patients undergoing radiation therapy
title_fullStr Pregnancy testing in patients undergoing radiation therapy
title_full_unstemmed Pregnancy testing in patients undergoing radiation therapy
title_short Pregnancy testing in patients undergoing radiation therapy
title_sort pregnancy testing in patients undergoing radiation therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533601/
https://www.ncbi.nlm.nih.gov/pubmed/28798811
http://dx.doi.org/10.3332/ecancer.2017.753
work_keys_str_mv AT kharodshivamm pregnancytestinginpatientsundergoingradiationtherapy
AT greenwaltjulie pregnancytestinginpatientsundergoingradiationtherapy
AT dessaignecamille pregnancytestinginpatientsundergoingradiationtherapy
AT yeunganamaria pregnancytestinginpatientsundergoingradiationtherapy